Meza Soto, E.A. (2025) “The Role of GLP-1 Receptor Agonists (Ozempic and Mounjaro) as Secondary Therapy in Chronic Kidney Disease”, Revista Científica Multidisciplinar SAGA, 2(3), pp. 973–991. doi:10.63415/saga.v2i3.257.